250 results on '"Bedford, Mark T"'
Search Results
2. The intrinsic substrate specificity of the human tyrosine kinome
3. Genome-wide screening identifies Trim33 as an essential regulator of dendritic cell differentiation
4. Functional characterization of QT interval associatedSCN5Aenhancer variants identify combined additive effects
5. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition
6. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma
7. Molecular basis for SPINDOC-Spindlin1 engagement and its role in transcriptional attenuation
8. CARM1 arginine methyltransferase as a therapeutic target for cancer
9. Abstract LB182: Targeting arginine methylation for improved therapy in triple negative breast cancer
10. Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
11. Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
12. Data from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
13. Data from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
14. Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
15. Effectors and effects of arginine methylation
16. Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
17. Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
18. Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
19. Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
20. Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
21. Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
22. Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
23. Supplementary Table 2 from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
24. Supplementary Table 1 from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
25. Data from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
26. Supplementary Table 1 from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
27. Supplementary Figure 1 from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
28. Supplementary Table 2 from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
29. Data from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
30. Supplementary Figure 1 from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
31. CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth
32. Supplementary Figure 8 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
33. Supplementary Figure 7 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
34. Supplementary Figure 6 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
35. Supplementary Figure 5 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
36. Supplementary Figure Legends 1-8 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
37. Supplementary Figure 8 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
38. Supplementary Figure 5 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
39. Supplementary Figures 1-4 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
40. Supplementary Figure Legends 1-8 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
41. Supplementary Figure 6 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
42. Supplementary Figure 7 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
43. Supplementary Figures 1-4 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
44. A complete methyl-lysine binding aromatic cage constructed by two domains of PHF2
45. The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer
46. PRMT5-Exacerbating Tumor Stemness and Immunosuppression Confer a Novel Therapeutic Vulnerability in Aggressive Prostate Cancer
47. A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP II
48. TWIST1 methylation by SETD6 selectively antagonizes LINC-PINT expression in glioma
49. Genome-wide analysis of dendritic cell differentiation
50. Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction–Reconstruction and Fragment-Growing Approach
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.